CompletedN/AMDMA

Perceptions of MDMA-Assisted Therapy Among Veterans With PTSD

Sponsored by Albany Research Institute, Inc.

NCT ID
NCT05895318
Target Enrollment
30 participants
Start Date
2022-08-08
Est. Completion
2023-03-23

About This Study

The goal of this exploratory, mixed-method design study is to gather qualitative and quantitative data obtained through interviews and questionnaires with veterans who are currently enrolled at the VA for healthcare. The main question this study aims to answer is: How do veterans diagnosed with PTSD and enrolled for care at the VA understand MDMA-assisted therapy for PTSD? Using a story-completion approach, participants will be provided with a brief story starter involving a fictitious character and scenario and asking them to complete the story. Few contextual details will be offered about the character. In responding to ambiguous cues, participants are thought to project their conscious and subconscious perceptions about the phenomenon in question onto the story, a useful method for exploring stigmatized topics. The purpose of this exercise is to ascertain the participants attitudes and perceptions regarding MDMA-Assisted Therapy.

Conditions Studied

Post Traumatic Stress Disorder

Eligibility

Age:18 Years - N/A
Healthy Volunteers:Yes
View full eligibility criteria
Inclusion Criteria:

* Veterans enrolled in VA care
* Active diagnosis of PTSD, as determined by the referring provider or confirmed by medical records.
* Age 18 or older
* Fluent in written and spoken English

Exclusion Criteria:

* Cognitively impaired to the extent that patient cannot comprehend the survey
* Has already completed the interview

Study Locations (1)

Stratton VA Medical Center
Albany, New York, United States

This trial is not recruiting

This study has completed enrollment. Check back for results or find similar trials.

Find recruiting trials
Data Source
ClinicalTrials.gov

Last updated from source

Perceptions of MDMA-Assisted Therapy Among Veterans With PTSD | Huxley